Gleevec

基本解释

Methods 6 CML-CP patients were respectively treated with 400mg/d Gleevec for 30 days,oral medications after meal.
方法6例CML-CP老年患者采用格列卫400mg/d,饭后1次口服,30天为1个疗程,随症处理;
When they tried Gleevec, known generically as imatinib, it had little effect on the cells.
当他们尝试着格列卫，通常被称依马替尼，它很少对细胞有作用。
In the US, under the Novartis GIPAP plan, Gleevec is free for all patients whose income is less than $46,000 USD a year.
这是另外一个病友发来的。年收入低于46000美元的美国人就可以免费吃格列卫。我们这也有免费的，但只对低保，我不知道低保啥概念，反正是极严极少。
In 1999, scientists were awed by the success of clinical trials testing a new targeted-therapy cancer drug called Gleevec.
1999年，一种经临床实验成功，名为格理威克的新的目标疗法癌症药物，让科学家们大开眼界。
The drug Gleevec, for example, was designed to inhibit an enzyme produced by a mutant fused version of two genes, called BCR-ABL, that causes chronic myelogenous leukemia.
以基利克（Gleevec）这个药物为例。基利克的设计是用来抑制某个造成慢性骨髓性白血症的酵素活性；该酵素是由BCR-ABL这两个基因混合而成的突变版本所生成。